Otros
Blastoid variant of mantle cell lymphoma in palatine tonsil
Date
2021-11-01Registration in:
Oral Oncology, v. 122.
1879-0593
1368-8375
10.1016/j.oraloncology.2021.105552
2-s2.0-85116170069
Author
Universidade Estadual Paulista (UNESP)
Pathology Institute of Araçatuba
Centro Universitário Católico Unisalesiano Auxilium
Hemotherapy Center of Araçatuba
Institutions
Abstract
Blastoid variant of mantle cell lymphoma (MCL) is an aggressive and extremely rare malignancy. MCL may be diagnosed in lymph nodes and/or extranodal sites exhibiting a poor prognosis. MCL with primary presentation in palatine tonsils has been rarely reported. Herein, we report the case of a 73-year-old man with a painless nodular mass on the right palatine tonsil. A biopsy was performed, and microscopic analysis revealed a neoplasm composed of small to medium sized lymphocytes with finely dispersed chromatin, roundish nucleus and many mitoses. The tumor cells were positive for CD20 (L26), CD5 (4C7), Cyclin D1 (EP12), Bcl2 (124) and Ki-67 (MIB-1; 90%), and negative for Bcl6 (PG-B6p), MUM1 (MUM1p) and CD3 (Polyclonal). These findings led to the diagnosis of blastoid variant of MCL. Diagnostic workup with computed tomography scan excluded other sites of disease. The patient was treated successfully with cyclophosphamide, doxorubicin, vincristine and prednisolone (mini-CHOP regimen). Although the blastoid variant of MCL is rare, it should be included in the differential diagnosis of rapid-growing masses in the palatine tonsil.
Related items
Showing items related by title, author, creator and subject.
-
Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
OLSEN, Elise A.; WHITTAKER, Sean; KIM, Youn H.; DUVIC, Madeleine; PRINCE, H. Miles; LESSIN, Stuart R.; WOOD, Gary S.; WILLEMZE, Rein; DEMIERRE, Marie-France; PIMPINELLI, Nicola; BERNENGO, Maria Grazia; ORTIZ-ROMERO, Pablo L.; BAGOT, Martine; ESTRACH, Teresa; GUITART, Joan; KNOBLER, Robert; SANCHES, Jose Antonio; IWATSUKI, Keiji; SUGAYA, Makoto; DUMMER, Reinhard; PITTELKOW, Mark; HOPPE, Richard; PARKER, Sareeta; GESKIN, Larisa; PINTER-BROWN, Lauren; GIRARDI, Michael; BURG, Guenter; RANKI, Annamari; VERMEER, Maartan; HORWITZ, Steven; HEALD, Peter; ROSEN, Steve; CERRONI, Lorenzo; DRENO, Brigette; VONDERHEID, Eric C. (AMER SOC CLINICAL ONCOLOGY, 2011)Mycosis fungoides (MF) and Sezary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin`s lymphomas. Clinical trials in MF/SS have ... -
CXCL12 rs1801157 Polymorphism in Patients with Breast Cancer, Hodgkin`s Lymphoma, and Non-Hodgkin`s Lymphoma
OLIVEIRA, Karen Brajao de; ODA, Julie Massayo Maeda; VOLTARELLI, Julio Cesar; NASSER, Thiago Franco; ONO, Mario Augusto; FUJITA, Thiago Cezar; MATSUO, Tiemi; WATANABE, Maria Angelica Ehara (WILEY-LISS, 2009)Chemokines and their receptors regulate the trafficking of immune cells during their development, inflammation, and tissue repair. The single-nucleotide polymorphism (SNP) rs1801157 (previously known as CXCL12-A/ stromal ...